Endovascular Engineering Raises $15M in Series A1 Funding

Endovascular Engineering

Endovascular Engineering, a Menlo Park, CA-based a preclinical stage company developing mechanical thrombectomy solutions to address peripheral indications, raised $15M in Series A1 funding.

The round was led by Santé Ventures and Cordis.

The company intends to use the funds to advance its thrombectomy platform through initial clinical evaluation.

Led by CEO Mike Rosenthal and Founder and CSO Dr. Luis Savastano, Endovascular Engineering develops thrombectomy devices to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). The E2 thrombectomy system was invented by Dr. Luis Savastano and developed in partnership with Inventure Group LLC, a Menlo Park based medical device incubator focused on developing next generation medical devices to meet the needs of patients and the physicians that treat them.